Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 103.44% vs -53.27% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 23.21% vs -48.39% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 54.16% vs -53.19% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 395.24% vs 5.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Tibet Rhodiola Pharmaceutical Holding Co. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 103.44% vs -53.27% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 41.34% vs -17.62% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 23.21% vs -48.39% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -27.03% vs 591.37% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 54.16% vs -53.19% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 28.77% vs 233.93% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 395.24% vs 5.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 10,300.00% vs -96.15% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






